ArticleNature communications2021

Suppression of tumor-associated neutrophils by lorlatinib attenuates pancreatic cancer growth and improves treatment with immune checkpoint blockade.

Sebastian R Nielsen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.